Si-Bone (SIBN) Interest Coverage Ratio (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.05% |
| Dec 31, 2025 | 51.34% |
| Sep 30, 2025 | 23.60% |
| Jun 30, 2025 | 6.93% |
| Mar 31, 2025 | -63.09% |
| Dec 31, 2024 | 19.76% |
| Sep 30, 2024 | 24.60% |
| Jun 30, 2024 | 16.22% |
| Mar 31, 2024 | 2.83% |
| Dec 31, 2023 | -11.34% |
| Sep 30, 2023 | 10.23% |
| Jun 30, 2023 | -4.44% |
| Mar 31, 2023 | -5.12% |
| Dec 31, 2022 | 28.65% |
| Sep 30, 2022 | 37.50% |
| Jun 30, 2022 | 4.39% |
| Mar 31, 2022 | -22.59% |
| Dec 31, 2021 | -393.91% |
| Sep 30, 2021 | 58.83% |
| Jun 30, 2021 | -10.86% |
| Mar 31, 2021 | -49.96% |
| Dec 31, 2020 | 7.85% |
| Sep 30, 2020 | -108.31% |
| Jun 30, 2020 | 60.85% |
| Mar 31, 2020 | -41.40% |
| Dec 31, 2019 | 19.81% |
| Sep 30, 2019 | -28.97% |
| Jun 30, 2019 | 7.74% |
| Mar 31, 2019 | -112.93% |
| Dec 31, 2018 | -41.49% |
| Sep 30, 2018 | -77.56% |
| Jun 30, 2018 | 41.55% |
| Mar 31, 2018 | -357.15% |
| Dec 31, 2017 | 90.02% |